Contrast Agents

Hall C
Monday: 14:00 – 16:00
Tuesday – Thursday: 13:30 – 15:30
T 1169. Hepatocellular Carcinoma on Ferumoxides-Enhanced T1-Weighted Gradient-Echo MR Imaging, K. Ueda, S. Hirohashi, H. Uchida, S. Kitano, N. Marugami and H. Ohishi, Nara Medical University, Nara, Japan.
1170. Abstract Withdrawn.
Th 1171. Magnetic Resonance Cholangiopancreatography: The Usefulness of A Negative Oral Contrast Agent – Mixture of Barium Sulfate and Magaldrate, G.C. Liu, T.S. Jaw, Y.T. Kuo, C.K. Wang and P.C. Sheen, Kaohsiung Medical College, Taiwan, ROC.
M 1172. Fecal Tagging with Swiss Chocolate and Gd-DOTA: A Path to Eliminate the Need for Colonic Cleansing Prior to MR-Colonography, M.A. Patak, D. Weishaupt, J. Froehlich, S.G. Ruehm, H.H. Quick and J.F. Debatin, University Hospital, Zurich, Switzerland.
T 1173. Sequential Fast 3D MRI Following Oral Ingestion of Gd-DOTA A New Means to Assess Intestinal Transit Time, M.A. Patak, D. Weishaupt, M. Schmidt and J.F. Debatin, University Hospital, Zurich, Switzerland.
W 1174. Detection of Intestinal Bleeding Sites: Assessment of a Non-Invasive Concept Based on 3D MRI and a Blood Pool Agent in Pigs, P.R. Hilfiker, D. Weishaupt, G.M. Kacl, F.H. Hetzer, N.M.T. Griff and J.F. Debatin, University Hospital, Zurich, Switzerland.
Th 1175. Evaluation of Arterial First Pass Contrast Medium Dynamics as a Function of Intravenous Injection Parameters, M. Boos, K. Scheffler, R. Haselhorst, E. Reese, P. Huber, J. Fröhlich and G. Bongartz, University-Hospital Basel, Switzerland.
M 1176. Characterization of T1 Relaxation and Blood-Myocardial Contrast Enhancement of NC100150 Injection in Cardiac MRI, J.E. Wagenseil, L.O.M. Johansson and C.H. Lorenz, Washington University Medical Center, St. Louis, MO, USA.
T 1177. Determining MRI Signal Intensity Threshold of Gadoteridol using the Nephrectomized Mouse, P. Wedeking, R. Shukla, Y.T. Kouch, A.D. Nunn and M.F. Tweedle, Bracco Research USA, Princeton, NJ, USA.
W 1178. In Vivo Imaging of Spin-Tapped Nitric Oxide (NO) in Septic-Shock Rats: MRI Spin-Trapping Method, H. Fujii, L.J. Berliner and K. Yoshikawa, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan; The Ohio State University, Columbus, OH, USA and The University of Tokyo, Tokyo, Japan.
Th 1179. Gadolinium Mesoporphyrin as a MRI Contrast Agent in the Evaluation of Tumors: An Experimental Model Using VX2 Carcinoma in Rabbits, T.K. Kim, B.I. Choi, S.W. Park, W. Lee, J.K. Han, M.C. Han and H.J. Weinmann, Seoul National University, Seoul, Korea and Schering AG, Berlin, Germany.
M 1180. Characterization of Mammary Carcinoma Using Gadolinium Encapsulating Liposomes, L.J. Wilmes, M.H. Gaber, M. Saeed, M.F. Wendland, K. Hong and N.M. Hylton, University of California, San Francisco, CA, USA.
T 1181. Towards Direct MRI Determination of the Thermodynamic (Interstitial) CR Concentrations in Tumors Following Bolus Injections, C.S. Landis, X. Li, J.A. Coderre, P.L. Micca, W.D. Rooney and C.S. Springer Jr., Brookhaven National Laboratory, Upton, NY, USA and State University of New York, Stony Brook, NY, USA.
W 1182. Quantitation of Active Phagocytic Kupffer Cells in the Liver: Evaluation of the Time of Steady State and the Effect of the Different Injection Dose of AMI-25, S-H. Kim, Y-M. Huh, S-J. Kim, J-S. Suh, E-K. Jeong, J-Y. Choi, H-J. Kim and J-K. Bong, Yonsei University, College of Medicine, Seoul, Korea.
Th 1183. The Usefulness of MnDPDP in MR Relaxometric Study of Liver, H. Kang, Y. Chang, H-J. Park, K-J. Suh, R.B. Clarkson and D-S. Kang, University of Illinois, Urbana-Champaign, IL, USA and Kyungpook National University Hospital, Taegu, Korea.
M 1184. Binding of Lipophilic MRI Contrast Agents to Albumin: A Spin-Labeling EPR Study, T.I. Smirnova, A.I. Smirnov, R.L. Belford and R.B. Clarkson, University of Illinois, Urbana, IL, USA.
T 1185. N-2-(Azol-1(2)-yl) Ethyliminodiacetic Acids; A Novel Series of Gd(III) Chelators as T2 Relaxation Agents for High Field Magnetic Resonance Imaging, P. López, C.G. Seipelt, P. Merkling, L. Sturz, A. Dölle, M.D. Zeidler, J. Álvarez, S. Cerdán and P. Ballesteros, UNED, Madrid, Spain; RWTH, Aachen, Germany and C.S.I.C., Madrid, Spain.
W 1186. Synthesis, Characterization, and Bio-Distribution of a Peptide Based MR Contrast Agent:
Protamine-Gd-DTPA, M-Y. Su, M.K. Samoszuk, Y. Song, A. Najafi and O. Nalcioglu, University of California, Irvine, CA, USA.
Th 1187. Fast T1 Measurement of Gd-DTPA Bolus Passage in Normal and Diseased Brain Using EPI, H.B.W. Larsson, S. Rosenbaum, I. Andersen and E. Rostrup, Hvidovre University Hospital, Copenhagen, Denmark.
M 1188. The Effects of Hematocrit on T2* of Blood in the Presence of Dy(III)DTPA-BMA and
Gd(III)DTPA-BMA, P.A. Schornack and W.H. Perman, Saint Louis University School of Medicine, St. Louis, MO, USA.
T 1189. Manganese Dipyridoxyl Diphosphate (MnDPDP): MRI Contrast Agent with Antioxidant and Cardioprotective Properties? H. Brurok, J.O.G. Karlsson, I. Laursen and P. Jynge, Norwegian University of Science and Technology, Trondheim, Norway; Linköping University, Linköping, Sweden and Danish University of Technology, Lyngby, Denmark.
W 1190. Relaxation Effects of Clustered Particles, A. Tanimoto, M. Suematsu, D. Pouliquen, D.D. Stark, Y. Yuasa and K. Hiramatsu, Keio University School of Medicine, Tokyo, Japan; Faculté de Médecine, Angers, France and University of Nebraska Medical Center, Omaha, NE, USA.
Th 1191. Dynamic Water Proton Relaxation in Human Venous Blood Following Double Gd-DTPA Administrations at 1.5 T Correlated with Intra-Vascular Contribution in BOLD fMRI, C.X. Tan, National Institutes of Health, Bethesda, MD, USA.
M 1192. Comparison of USPIO and a Prototype Macromolecular Contrast Agent in Their Abilities to Estimate Permeability Changes of the Blood Bone Marrow Barrier, H.E. Daldrup, T.M. Link, D. Wiedermann, S. Könemann, S. Blasius, W. Heindel and E.J. Rummeny, University Hospital of Muenster, Germany.
T 1193. Effects of Local Diffusion Coefficient in Image Contrast, K-T. Yung and P.C. Lauterbur, University of Illinois, Urbana, IL, USA.
W 1194. Multisite Evaluation of Precision of NMRD, R.B. Shukla, J. Tian, S. Eaton, S.A. Klinger, A.D. Nunn and M.F. Tweedle, Bracco Research USA, Princeton, NJ, USA.
Th 1195. Quantification of Macroscopic Susceptibility Effects in Whole Body 1.5T and 8T MRI Systems, A.M. Abduljalil, R. Burgess, S.M. Lee, D.W. Chakeres, A. Kangru, B. Xu, B.D. Clymer, P. Schmalbrock and P.M. Robitaille, The Ohio State University, Columbus, OH, USA.
M 1196. Dynamic Relaxometry: Application to Iron Uptake by Ferritin, V. Herynek, J.W.M. Bulte, T. Douglas and R.A. Brooks, National Institutes of Health, Bethesda, MD, USA and Temple University, Philadelphia, PA, USA.
T 1197. Determination of pH Using Water Proton Chemical Exchange: Potential pH Sensitive MRI Contrast Agents, K.M. Ward and R.S. Balaban, National Institutes of Health, Bethesda, MD, USA.
W 1198. Equilibrium Transcytolemmal Water Exchange in Vivo, C.S. Landis, X. Li, G. Vetek and C.S. Springer, Brookhaven National Labaratory, Upton, NY, USA and State University of New York, Stony Brook, NY, USA.
Th 1199. Statistical Analysis of Contrast Enhanced MRI Data, R.G. Pautler and A.P. Koretsky, Carnegie Mellon University, Pittsburgh, PA, USA.
M 1200. Phase III Double-Blind, Efficacy Evaluation of Gadobenate Dimeglumine (MultiHance™) in Malignant Lesions of the Brain, V.M. Runge, D.L. Rubin, V.M. Haughton, R.G. Barr, K.R. Maravilla and M.J. Kuhn, University of Kentucky, Lexington, KY, USA.
T 1201. Evaluation of Fractional Blood Volume by Means of Functional Blood Pool Mapping in Experimentally Induced Rat Liver Tumors Using Dynamic MRI with Ultrasmall Iron Oxide Particles (USPIO), C. Poeckler-Schoeniger, J. Koepke, O. Schueler, W. Schreiber, M. Georgi and P. Bannasch, University of Heidelberg, Mannheim, Germany.
W 1202. Modeling Gd-DTPA Contrast Agent Kinetics Using a Reference Tissue, D.L. Buckley, L. Rice, P. Narayan and S.J. Blackband, University of Florida, Gainesville, FL, USA.
Th 1203. Analysis of Dynamic Contrast-Enhanced MRI in Tumors: Optimization of Acquisition Parameters, S. Krishnan, T. Chenevert and J.L. Evelhoch, University of Michigan, Ann Arbor, MI, USA and Wayne State University, Detroit, MI, USA.
M 1204. Measurement of Gd-DTPA Concentration in Flowing Blood with MRI, J.O. Fredrickson, F.G. Sommer and N.J. Pelc, Stanford University, Stanford, CA, USA.
T 1205. Monte Carlo Simulation Study to Determine the Confidence Limits for the Plasma and Tissue Concentration Time Curves in Dynamic Gd-DTPA Enhanced MRI, C. Karmonik and E.F. Jackson, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Return to Poster Sessions

Return to ISMRM Program